Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MAIL SERVICE PHARMACY DRUG "WASTAGE RATE"

Executive Summary

MAIL SERVICE PHARMACY DRUG "WASTAGE RATE": about 2.5% of a 90-day mail order supply is not used compared with approximately .8% for typical 30-day supply from a retail outlet, according to a recent study prepared for the Medco mail order pharmacy services group. The larger 2.5% "wastage rate" has "minimal" impact on the potential cost savings from mail service plans, the study maintains. The study, a cost comparison of mail service, traditional major medical and third-party card dispensing plans, was conducted for Medco by the Boston Consulting Group. The amount of unused drugs found in 90-day mail service plans "is not a serious problem," due to factors offsetting the cost of wasted drugs, a summary of the report said. However, the report adds, "the unused drug rate does increase substantially . . . to 6.1% for 180-day MSP [mail service pharmacy] plans." Therefore, the "optimal range of days dispensed" in terms of cost savings is between 72 and 120. Despite more unused drugs and higher drug utilization, the study found that the potential per unit cost savings on maintenance drugs from mail service plans is 30%-35% higher than with major medical or card plans. Medco says it has confirmed this cost savings potential in a second study, scheduled to be released "shortly." Because mail service plans offer first-dollar coverage, the expected utilization rate is 10%-20% higher than major medical plans, which usually include a deductible, the report notes. Factors contributing to lower mail service costs include an estimated 10%-30% in ingredient price discounts to customers on the average wholesale price (AWP) of ingredients. Card plans "generally offer no discounts" and major medical plan ingredient prices "are marked up substantially over AWP," the report stated. Higher generic dispensing rates in mail service plans also reduce costs, the study said, estimating that generic dispensing rates for mail service plans are approximately 24% for maintenance drugs versus 12% at retail pharmacies. Further, the report noted, most mail service plans charge no administrative fees, which may account for over 15% of total costs in major medical plans. Maintenance drugs "typically represent 70%-80% of total drug expenditures," the study noted. Therefore, when mail service unit cost savings of 30%-35% are translated to the total drug bill, savings are reduced somewhat, to 20%-25%, the report said. The total drug bill represents the net cost for the employer and employee, per employee, per year.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

Latest Headlines
See All
UsernamePublicRestriction

Register

PS012570

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel